| Name | Shares allotted | % of global offering | % of post-IPO shares | Lock-up |
|---|---|---|---|---|
| ADIA | 2,699,000 | 9.74% | 0.70% | 6 months |
| UBS AM Singapore | 1,799,300 | 6.50% | 0.50% | 6 months |
The IPO drew massive enthusiasm with an oversubscription of 1,091.94 times, signaling extremely strong market appetite. The overall hit rate of only 10.18% underscores fierce competition for allocations, typical for a hot biotech offering under Chapter 18A. The final offer price was set at HKD 43.24, but without the initial price range, pricing dynamics are unclear. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Detailed tier subscription data is not available in the source, so specific anomalies like a narrow gap between 甲尾 and 乙头 or unusual winner ratios cannot be assessed. With such a high oversubscription, the distribution of lots is likely concentrated among the largest applications, potentially disadvantaging smaller subscribers. Broker fee efficiency comparisons are not feasible without tier-level allocation information. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Mainland Chinese investors comprised 61.9% of the total holders, reflecting strong cross-border interest in Hong Kong-listed biotech firms. The gender split was 59.8% male and 40.2% female, with an average investor age of 44.2 years, indicating a mature demographic. The high mainland participation aligns with the growing appetite for innovative healthcare assets from China-based investors. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
This page shows allotment analysis for Edge Medical-B (02675): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

